Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Idiopathic CD4 Lymphocytopenia: It’s Time for Answers

Sunday, September 29, 2013
San Francisco, CA

This conference aims to reignite interest in determining the etiology of ICL, understanding the immunologic mechanisms that distinguish ICL from the CD4 Lymphocytopenia seen in other conditions such as HIV/AIDS or chemotherapy, and investigating potential treatments for ICL.

Irini Sereti, MD, (301) 496-5533

Co-funding Institute(s):
National Institute of Allergy and Infectious Diseases
Office of Rare Diseases Research

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.